Liu Hang, Zhao Long, Zhang Jisheng, Li Chenyu, Shen Xuefei, Liu Xuemei, Jiang Wei, Luo Congjuan, Wang Yanfei, Che Lin, Xu Yan
Department of Nephropathy, The Affiliated Hospital of Qingdao University, Qingdao, China.
Key Laboratory, Department of Otolaryngology-Head and Neck Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Front Physiol. 2019 May 3;10:464. doi: 10.3389/fphys.2019.00464. eCollection 2019.
To explore the expression of cysteine-rich protein 61 (Cyr61) in ischemic renal fibrosis and the role of Cyr61 in mediating the activation of renal fibroblasts.
(1) The rat model of renal fibrosis was established after ischemia-reperfusion acute renal injury (IR-AKI). We detected the renal function by biochemical test, evaluated the fibrosis by Masson staining, and detected the expression of Cyr61 by western blotting. (2) Bioinformatics technique was adopted to analyze the expression of Cyr61 in activated renal fibroblasts. (3) Normal rat kidney fibroblast cells (NRK-49F cells) with over-expression of Cyr61 (Cyr61) and low-expression of it (Cyr61) were established by plasmid transfection. Then part of the cells were activated by TGF-β1 and NRK-49F cells were divided into control group, activated group, Cyr61/Cyr61 group and Cyr61/Cyr61 activated group. The expression of Cyr61 and fibrosis related factors (Col1α1, Col3α1, MMP9, and MMP13) were ascertained by PCR and western blotting. Cell proliferation was discovered by CCK8 method, cell cycle was analyzed by flow cytometry, and the transcription of cell senescence related factors (P53, P21, Rb, and P16) were ascertained by PCR method.
(1) In the process of fibrosis after IR-AKI, the area of collagen fiber was most obviously at AKI 1W, while the Cyr61 protein was at the lowest level at AKI 1W. (2) Gene chip analysis showed that the expression of Cyr61 was decreased in renal fibroblasts after IR. (3) Compared with control group, Cyr61 group expressed less Col1α1 or Col3α1, as well as more MMP9 and MMP13. At the same time, the proliferation of Cyr61 group decreased and cells in G1 phases increased with more transcription of P53, P21, and Rb (all < 0.05). Compared with activated group, the results of Cyr61 activated group were similar to the above. The above effects of low expression group were just the opposite. In addition, there was no difference in the transcription of P16 among these groups ( > 0.05).
Cyr61 may not only inhibit the fibrotic phenotype of fibroblasts, but may also inhibit proliferation by promoting fibroblasts arrest in G1 phase through the P53/P21/Rb interrelated cell senescence pathway, subsequently affecting the process of ischemic renal fibrosis.
探讨富含半胱氨酸蛋白61(Cyr61)在缺血性肾纤维化中的表达及Cyr61在介导肾成纤维细胞活化中的作用。
(1)建立缺血再灌注急性肾损伤(IR-AKI)后大鼠肾纤维化模型。通过生化检测评估肾功能,采用Masson染色评估纤维化程度,并用蛋白质印迹法检测Cyr61的表达。(2)采用生物信息学技术分析Cyr61在活化肾成纤维细胞中的表达。(3)通过质粒转染建立Cyr61过表达(Cyr61)和低表达(Cyr61)的正常大鼠肾成纤维细胞(NRK-49F细胞)。部分细胞用转化生长因子-β1激活,NRK-49F细胞分为对照组、活化组、Cyr61/Cyr61组和Cyr61/Cyr61活化组。通过聚合酶链反应(PCR)和蛋白质印迹法确定Cyr61及纤维化相关因子(Col1α1、Col3α1、基质金属蛋白酶9(MMP9)和基质金属蛋白酶13(MMP13))的表达。采用细胞计数试剂盒8(CCK8)法检测细胞增殖,通过流式细胞术分析细胞周期,并用PCR法确定细胞衰老相关因子(P53、P21、视网膜母细胞瘤蛋白(Rb)和P16)的转录情况。
(1)在IR-AKI后的纤维化过程中,胶原纤维面积在急性肾损伤1周(AKI 1W)时最明显,而Cyr61蛋白在AKI 1W时处于最低水平。(2)基因芯片分析显示,IR后肾成纤维细胞中Cyr61的表达降低。(3)与对照组相比,Cyr61组Col1α1或Col3α1表达较少,而MMP9和MMP13表达较多。同时,Cyr61组细胞增殖减少,G1期细胞增多,P53、P21和Rb的转录增加(均P<0.05)。与活化组相比,Cyr61活化组的结果与上述相似。低表达组的上述作用则相反。此外,各组间P16的转录无差异(P>0.05)。
Cyr61不仅可能抑制成纤维细胞的纤维化表型,还可能通过P53/P21/Rb相关的细胞衰老途径促进成纤维细胞停滞于G1期来抑制增殖,进而影响缺血性肾纤维化的进程。